{"authors": [["Morieri", "Mario Luca", "ML", "Joslin Diabetes Center, Research Division, Department of Genetic & Epidemiology, Boston, USA; University of Ferrara, Department of Medical Science, Ferrara, Italy."], ["Shah", "Hetal S", "HS", "Joslin Diabetes Center, Research Division, Department of Genetic & Epidemiology, Boston, USA; Harvard Medical School, Department of Medicine, Boston, USA."], ["Lovato", "Laura", "L", "Wake Forest School of Medicine, Winston Salem, USA."], ["Mychaleckyj", "Josyf C", "JC", "University of Virginia, Center for Public Health Genomics, Charlottesville, USA."], ["Ginsberg", "Henry N", "HN", "Wake Forest School of Medicine, Winston Salem, USA; Columbia University, Irving Institute for Clinical and Translational Research, New York, USA."], ["Doria", "Alessandro", "A", "Joslin Diabetes Center, Research Division, Department of Genetic & Epidemiology, Boston, USA; Harvard Medical School, Department of Medicine, Boston, USA."]], "text": "", "id": "29366108", "date": "2017-08-12", "title": "Increase in apoliporotein-A2 Levels is associated with lower cardiovascular risk in the accord lipid trial.", "doi": "10.1016/j.atherosclerosis.2017.06.151", "journal": ["Atherosclerosis", "Atherosclerosis"]}